Richly annotated data and/or specimens spanning 12+ years of the I-SPY trial are available to approved investigators by completing an I-SPY Concept Proposal.
Richly annotated data and/or specimens spanning 12+ years of the I-SPY trial are available to approved investigators by completing an I-SPY Concept Proposal.
The Data Access and Publications Committee (DAPC) reviews all proposals to ensure scientific rigor, feasibility, and alignment with QLHC's mission to accelerate patient-centric research.
Approved investigators gain access to one of medicine's most comprehensive multi-modal clinical datasets. Submit a proposal to the DAPC to begin your research journey with QLHC.
Quantum Discovery is Quantum Leap Healthcare Collaborative's secure data fabric platform — purpose-built to operationalize and analyze one of medicine's most comprehensive multi-modal clinical datasets. This is not a data lake. It is an active, governed, integrated environment where clinical trial data becomes a tool for discovery.
Across QLHC's portfolio of adaptive platform trials — including I-SPY 2.2, I-SPY Phase 1b, RECAST DCIS, EOP, I-SPY COVID, and ISPY ARDS — Quantum Discovery provides access to a rare depth of longitudinally collected, richly annotated data.
DAPC-approved investigators gain secure, structured access to Quantum Discovery's curated data fabric — without building the data infrastructure themselves. Whether your research centers on biomarker discovery, treatment response modeling, or disease biology across oncology and critical care, Quantum Discovery delivers the data you need in a format ready for analysis.
Drug development decisions need multi-modal, longitudinal evidence — not snapshot datasets. Quantum Discovery gives biopharma partners governed access to clinical, genomic, imaging, and liquid biopsy data collected across QLHC's adaptive trials — spanning breast cancer, DCIS, and critical illness — in an architecture purpose-built for the analytical demands of modern drug development.
Built to meet the standards leading research funders are requiring, Quantum Discovery is where rigorous adaptive trial design meets next-generation data operationalization.
Quantum Discovery maintains the highest standards for data governance, security, compliance, and patient privacy. All access is granted through a rigorous approval process, ensuring that data is used responsibly to advance science and improve patient outcomes.